{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:11:59Z","timestamp":1790856719213,"version":"4.1.0"},"reference-count":137,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1675,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1478-3231.2011.02449.x","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T09:07:50Z","timestamp":1296464870000},"page":"443-460","source":"Crossref","is-referenced-by-count":45,"title":["Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment"],"prefix":"10.1111","volume":"31","author":[{"given":"Manuel","family":"Romero-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Maraver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,30]]},"reference":[{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB1|cit1","first-page":"157","article-title":"Acute hepatitis C","volume":"22","author":"Morin","year":"2010","journal-title":"analysis of a 126-case prospective, multicenter cohort"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB2|cit2","first-page":"34","article-title":"Spontaneous viral clearance following acute hepatitis C infection","volume":"13","author":"Micallef","year":"2006","journal-title":"a systematic review of longitudinal studies"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1073\/pnas.0907439106","article-title":"A genome-wide genetic screen for host factors required for hepatitis C virus propagation","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genome wide association study of leprosy","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature02326","article-title":"Susceptibility to leprosy is associated with PARK2 and PACRG","volume":"427","author":"Mira","year":"2004","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ng1550","article-title":"A variant in the CD209 promoter is associated with severity of dengue disease","volume":"37","author":"Sakuntabhai","year":"2005","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ng.388","article-title":"Genome-wide and fine-resolution association analysis of malaria in West Africa","volume":"41","author":"Jallow","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ng.348","article-title":"A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians","volume":"41","author":"Kamatani","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ng1976","article-title":"A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis","volume":"39","author":"Khor","year":"2007","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/gast.1997.v113.pm9352872","article-title":"Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection","volume":"113","author":"Alric","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB13|cit13","first-page":"7302","article-title":"Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection","volume":"11","author":"Hong","year":"2005","journal-title":"a meta-analysis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.23515","article-title":"Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia","volume":"51","author":"Kuniholm","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2","article-title":"Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection","volume":"54","author":"H\u00f6hler","year":"1998","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB16|cit16","first-page":"1356","article-title":"An assessment of a TNF polymorphic marker for the risk of HCV infection","volume":"9","author":"Chen","year":"2009","journal-title":"meta-analysis and a new clinical study design"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"e1000294","DOI":"10.1371\/journal.pbio.1000294","article-title":"Rare variants create synthetic genome-wide associations","volume":"8","author":"Dickson","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.23477","article-title":"Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus","volume":"51","author":"Knapp","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.molimm.2009.05.014","article-title":"Protective KIR-HLA interactions for HCV infection in intravenous drug users","volume":"46","author":"Z\u00fa\u00f1iga","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.humimm.2006.02.001","article-title":"HLA-C and KIR genes in hepatitis C virus infection","volume":"66","author":"Montes-Cano","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB22|cit22","first-page":"404","article-title":"Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection","volume":"22","author":"Constantini","year":"2002","journal-title":"an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0198-8859(03)00080-6","article-title":"IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection","volume":"64","author":"Lio","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.10472","article-title":"Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection","volume":"71","author":"Barrett","year":"2003","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cyto.2003.10.005","article-title":"IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection","volume":"25","author":"Mangia","year":"2004","journal-title":"Cytokine"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2004.06.021","article-title":"Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection","volume":"41","author":"Mueller","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jir.2005.25.271","article-title":"Polymorphisms in the IL-12B gene and outcome of HCV infection","volume":"25","author":"Houldsworth","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.gene.6364188","article-title":"Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance","volume":"6","author":"Oleksyk","year":"2005","journal-title":"Genes Immun"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.00339-06","article-title":"Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism","volume":"80","author":"Paladino","year":"2006","journal-title":"J Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1478-3231.2007.01518.x","article-title":"Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection","volume":"27","author":"Hennig","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/592047","article-title":"Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance","volume":"198","author":"An","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.humimm.2004.11.001","article-title":"Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes","volume":"66","author":"Minton","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2006.03.011","article-title":"Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan","volume":"34","author":"Kusumoto","year":"2006","journal-title":"Cytokine"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.1997.4861382.x","article-title":"Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease","volume":"109","author":"Kakumu","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1086\/503436","article-title":"Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus","volume":"193","author":"Kimura","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2006.09.011","article-title":"Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection","volume":"46","author":"Schott","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/01.meg.0000224478.89545.76","article-title":"Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection","volume":"18","author":"Wietzke-Braun","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jir.2007.0049","article-title":"Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes","volume":"28","author":"Fortunato","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2249.2004.02444.x","article-title":"Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients","volume":"136","author":"Mascheretti","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB40|cit40","first-page":"1157","article-title":"The CCR5-delta32 mutation","volume":"54","author":"Goulding","year":"2005","journal-title":"impact on disease outcome in individuals with hepatitis C infection from a single source"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1179\/136485908X337599","article-title":"In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection","volume":"102","author":"Elsammak","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2156-9-80","article-title":"A globally occurring indel polymorphism in the promoter of the IFNA2 gene is not associated with severity of malaria but with the positivity rate of HCV","volume":"9","author":"Tena-Tom\u00e1s","year":"2008","journal-title":"BMC Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0609954104","article-title":"A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2893.2009.01166.x","article-title":"Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection","volume":"17","author":"Bekker","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.gene.6363883","article-title":"Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection","volume":"3","author":"Hennig","year":"2002","journal-title":"Genes Immun"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.meegid.2009.05.002","article-title":"Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection","volume":"9","author":"Mas Marques","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cca.2008.12.001","article-title":"Association of functional polymorphism of ApoB promoter with hepatitis C virus infection","volume":"401","author":"Zhu","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2009.08.037","article-title":"Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor","volume":"394","author":"Owen","year":"2009","journal-title":"Virology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.23278","article-title":"Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles","volume":"51","author":"Benga","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/jhep.2002.34745","article-title":"Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus","volume":"36","author":"Wozniak","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.2005.079905","article-title":"Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection","volume":"55","author":"Price","year":"2006","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cccn.2005.05.024","article-title":"Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection","volume":"361","author":"Ferr\u00e9","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","article-title":"IL28B genetic variants and hepatitis virus infection by different viral genotypes","volume":"52","author":"Montes-Cano","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB56|cit56","first-page":"1338","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment Failure","volume":"138","author":"Rauch","year":"2010","journal-title":"a genome-wide association study"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"issue":"(S","key":"10.1111\/j.1478-3231.2011.02449.x-BIB58|cit58","first-page":"S3","article-title":"National Institute of Health Consensus Development Conference Statement","volume":"36","year":"2002","journal-title":"management of hepatitis C: 2002 - June 10-12, 2002"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB60|cit60","first-page":"493","article-title":"Genetic polymorphisms and the progression of liver fibrosis","volume":"37","author":"Bataller","year":"2003","journal-title":"a critical appraisal"},{"issue":"(S","key":"10.1111\/j.1478-3231.2011.02449.x-BIB61|cit61","first-page":"217","article-title":"DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C","volume":"7","author":"Kryczka","year":"2001","journal-title":"Med Sci Monit"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.48.5.714","article-title":"Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease","volume":"48","author":"Tillmann","year":"2001","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gut.51.4.585","article-title":"Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels","volume":"51","author":"Renou","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/341086","article-title":"Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease","volume":"186","author":"Hue","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.21040","article-title":"HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C","volume":"43","author":"Patel","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB66|cit66","first-page":"548","article-title":"DNA polymorphisms and response to treatment in patients with chronic hepatitis C","volume":"49","author":"Morgan T","year":"2008","journal-title":"results from the HALT-C trial"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/jhep.2003.09027","article-title":"Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection","volume":"38","author":"Hellier","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2893.2004.00510.x","article-title":"Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies","volume":"11","author":"Ruiz-Ferrer","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3748\/wjg.v12.i29.4721","article-title":"CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C","volume":"12","author":"Goyal","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2003.50061","article-title":"Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C","volume":"124","author":"Promrat","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0016-5085(03)01213-7","article-title":"A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease","volume":"125","author":"Muhlbauer","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1053\/j.gastro.2004.04.039","article-title":"The_2518 promotor polymorphism in the MCP-1 gene is not associated with liver cirrhosis in chronic hepatitis C virus infection","volume":"126","author":"Glas","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1053\/j.gastro.2005.08.047","article-title":"No role of the _2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C [Correspondence]","volume":"128","author":"Bonkovsky","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1478-3231.2008.01725.x","article-title":"Association of IRF-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients","volume":"28","author":"Sermasathanasawadi","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature06730","article-title":"Translational control of the innate immune response through IRF-7","volume":"452","author":"Colina","year":"2008","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.1840380409","article-title":"Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C","volume":"38","author":"Leroy","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB77|cit77","first-page":"2861","article-title":"Increased expression of T cell chemokines and their receptors in chronic hepatitis C","volume":"97","author":"Apolinario","year":"2002","journal-title":"relationship with the histological activity of liver disease"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.gene.6364168","article-title":"Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection","volume":"6","author":"Hofer","year":"2005","journal-title":"Genes Immun"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.3748\/wjg.v11.i42.6656","article-title":"Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3","volume":"11","author":"Abbas","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.3748\/wjg.15.5610","article-title":"Polymorphisms of some cytokines and chronic hepatitis B and C virus infection","volume":"15","author":"Gao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12072-009-9127-0","article-title":"Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients","volume":"3","author":"Manohar","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jmv.21079","article-title":"Association of Interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection","volume":"80","author":"Bouzgarrou","year":"2008","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/jmv.20662","article-title":"Studies on TAQ1 polymorphism in the 30 untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3","volume":"78","author":"Suneetha","year":"2006","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2893.2006.00767.x","article-title":"Associations of tumour necrosis factor alpha promoter polymorphisms at position 308 and _238 with clinical characteristics of chronic hepatitis C","volume":"13","author":"Dai","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(03)00029-9","article-title":"Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha","volume":"59","author":"Yu","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.gene.6363696","article-title":"Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection","volume":"1","author":"Yee","year":"2000","journal-title":"Genes Immun"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/jhep.2002.34745","article-title":"Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus","volume":"36","author":"Wozniak","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.trsl.2006.04.005","article-title":"Polymorphism of interferon-gamma gene at position 1874 and clinical characteristics of chronic hepatitis C","volume":"148","author":"Dai","year":"2006","journal-title":"Transl Res"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB89|cit89","first-page":"411","article-title":"Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection","volume":"4","author":"Knapp","year":"2003","journal-title":"roles of MxA, OAS-1 and PKR"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1478-3231.2009.02061.x","article-title":"Polymorphism of OAS-1determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication","volume":"29","author":"Li","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03264.x","article-title":"Severe fibrosis in hepatitis C virus infected patients is associated with increased activity of the mannan-binding-lectin (MBL)\/MBL-associatedserine protease 1 (MASP-1) complex","volume":"147","author":"Brown","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB92|cit92","first-page":"258","article-title":"Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C","volume":"152","author":"Alves Pedroso","year":"2008","journal-title":"association with the severity of liver fibrosis and response to interferon therapy"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.21636","article-title":"Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus","volume":"46","author":"Yee","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0168-8278(02)00018-1","article-title":"Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection","volume":"36","author":"Diwakaran","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB95|cit95","first-page":"91","article-title":"Hepatic stellate cells in hepatitis C patients","volume":"19","author":"Martinelli","year":"2004","journal-title":"relationship with liver iron deposits and severity of liver disease"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<21::AID-JMV4>3.0.CO;2-F","article-title":"Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis","volume":"60","author":"Negro","year":"2000","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1309\/TRB1-JXUJ-L9R6-9NHX","article-title":"Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations","volume":"113","author":"Pirisi","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.50.2.248","article-title":"The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C","volume":"50","author":"Thorburn","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB99|cit99","first-page":"335","article-title":"HFE mutations and chronic hepatitis C","volume":"38","author":"Erhardt","year":"2003","journal-title":"H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrosis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB100|cit100","first-page":"318","article-title":"Hepatitis C, iron status, and disease severity","volume":"124","author":"Tung","year":"2003","journal-title":"relationship with HFE mutations"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB101|cit101","first-page":"178","article-title":"Factores agravantes de la lesi\u00f3n hep\u00e1tica en la hepatitis C","volume":"25","author":"Romero G\u00f3mez","year":"2002","journal-title":"Rev And Pat Digest"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB102|cit102","first-page":"780","article-title":"Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C","volume":"81","author":"Gehrke","year":"2003","journal-title":"impact on iron status, liver injury and HCV genotype"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0168-8278(02)00305-7","article-title":"Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C","volume":"37","author":"Bonkovsky","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/gut.2003.028274","article-title":"SLC11a1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C","volume":"53","author":"Romero-Gomez","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0168-8278(02)00272-6","article-title":"Pirfenidone effectively reverses experimental liver fibrosis","volume":"37","author":"Garcia","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0009-8981(01)00738-0","article-title":"Association of polymorphisms of the transforming growth factor-1 gene with the rate of progression of HCV-induced liver fibrosis","volume":"316","author":"Gewaltig","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/he.2000.6253","article-title":"Host genetic factors influence disease progression in chronic hepatitis C","volume":"31","author":"Powell","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jmv.21011","article-title":"Association of TGF-1 Codon 25 (G915C) Polymorphism with hepatitis C virus infection","volume":"80","author":"Pereira","year":"2008","journal-title":"J Med Virol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2310\/JIM.0b013e3181891512","article-title":"Fibrogenic polymorphisms (TGF-\u03b2, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment","volume":"56","author":"Armendariz-borunda","year":"2008","journal-title":"J Invest Med"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1572-0241.2004.04092.x","article-title":"Genetic and acquired thrombotic factors in chronic hepatitis C","volume":"99","author":"Poujol-Robert","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","author":"Poujol-Robert","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1440-1746.2007.05220.x","article-title":"Effect of a thrombin receptor (protease-activated receptor 1,PAR-1) gene polymorphism in chronic hepatitis C liver Fibrosis","volume":"23","author":"Martinelli","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.gene.6363880","article-title":"A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection","volume":"3","author":"Reynolds","year":"2002","journal-title":"Genes Immun"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cld.2008.03.002","article-title":"Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus","volume":"12","author":"Thio","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2006.02.032","article-title":"Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C","volume":"130","author":"Huang","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jhep.2009.04.027","article-title":"Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection","volume":"51","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","article-title":"A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C","volume":"50","author":"Marcolongo","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-G\u00f3mez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(03)00287-3","article-title":"Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens","volume":"39","author":"Asahina","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2893.2004.00509.x","article-title":"Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection","volume":"11","author":"Suzuki","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.hep.2003.09.042","article-title":"Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1","volume":"38","author":"Mueller","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000073218","article-title":"Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism","volume":"68","author":"Schiemann","year":"2003","journal-title":"Digestion"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-8278(01)00243-4","article-title":"Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin","volume":"36","author":"Vidigal","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jhep.2001.22347","article-title":"Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection","volume":"33","author":"Yee","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1572-0241.2003.07537.x","article-title":"HLA class I B44 is associated with sustained response to interferon+ribavirin therapy in patients with chronic hepatitis C","volume":"98","author":"Romero-Gomez","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1180A","DOI":"10.1016\/S0168-8278(10)61181-6","article-title":"A chromosome 19 SNP (rs12979860) predicts outcome (EVR\/SVR) in HCV patients treated with interferon, independent of pegylation or ribavirin","volume":"52","author":"Asselah","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1053\/j.gastro.2010.02.009","article-title":"Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin","volume":"138","author":"McCarthy","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"644A","DOI":"10.1016\/S0168-8278(10)60646-0","article-title":"Genome-wide association and high throughput genotype imputation studies confirm a susceptibility locus to HCV infection on 6p22.1-p21.31","volume":"52","author":"Del Campo","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"IL28B polymorphism improves viral kinetics and is the strongest pre-treatment predictor of SVR in HCV-1 patients","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"Predictive role of IL28B C\/C genotype on SVR and RVR in patients with genotype 2\/3 chronic infection","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB135|cit135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2010.07.019","article-title":"Impact of the IL28B-genotype on early and sustained virologic response in treatment-na\u00efve patients with chronic hepatitis C treated with Peg-Interferon-\u03b12a and Ribavirin","author":"St\u00e4ttermayer","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M109.002923","article-title":"Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family","volume":"284","author":"Gad","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1478-3231.2011.02449.x-BIB137|cit137","first-page":"357","article-title":"Genomics","volume":"461","author":"Iadonato","year":"2009","journal-title":"hepatitis C virus gets personal"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2011.02449.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2011.02449.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T01:12:03Z","timestamp":1685927523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2011.02449.x"}},"subtitle":["Genes and hepatitis C"],"short-title":[],"issued":{"date-parts":[[2011,1,30]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02449.x","relation":{},"ISSN":["1478-3223"],"issn-type":[{"value":"1478-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,30]]}}}